corticosterone has been researched along with Acute-Phase Reaction in 33 studies
Acute-Phase Reaction: An early local inflammatory reaction to insult or injury that consists of fever, an increase in inflammatory humoral factors, and an increased synthesis by hepatocytes of a number of proteins or glycoproteins usually found in the plasma.
Excerpt | Relevance | Reference |
---|---|---|
"The plasma level of angiotensinogen during the chronic phase of inflammation was studied for comparison with those of other acute-phase reactants in rat adjuvant arthritis." | 7.67 | Acute-phase response of angiotensinogen in rat adjuvant arthritis. ( Hanaoka, M; Itoh, N; Ohtani, R; Okamoto, H; Yayama, K, 1989) |
" rIL-18 did not induce leukocytosis, or changes of circulating concentrations of lipoproteins and corticosterone in mice." | 3.73 | Interleukin-18 does not modulate the acute-phase response. ( Dinarello, CA; Kullberg, BJ; Netea, MG; Stuyt, RJ; van der Meer, JW; Verschueren, I, 2005) |
"The plasma level of angiotensinogen during the chronic phase of inflammation was studied for comparison with those of other acute-phase reactants in rat adjuvant arthritis." | 3.67 | Acute-phase response of angiotensinogen in rat adjuvant arthritis. ( Hanaoka, M; Itoh, N; Ohtani, R; Okamoto, H; Yayama, K, 1989) |
"Schizophrenia is associated with increased risk for multiple metabolic abnormalities, including altered glucose homeostasis, type-2 diabetes, obesity, and cardiovascular disease." | 1.39 | Priming of metabolic dysfunctions by prenatal immune activation in mice: relevance to schizophrenia. ( Giovanoli, S; Langhans, W; Meyer, U; Pacheco-López, G, 2013) |
"Corticosterone was unaffected by CFA in either species, but elevated in both relative to free-living individuals." | 1.36 | Variation in inflammation as a correlate of range expansion in Kenyan house sparrows. ( Alam, JL; Imboma, T; Liebl, AL; Martin, LB, 2010) |
"When endotoxic shock was induced, the LPS-induced hypoglycemia developed in WN rats was abolished in UN animals, and both ACTH and TNF plasma concentrations after endotoxin, albeit significantly (p < 0." | 1.31 | Metabolic, neuroendocrine and immune functions in basal conditions and during the acute-phase response to endotoxic shock in undernourished rats. ( Chisari, AN; Corró, L; Gaillard, RC; Giovambattista, A; Spinedi, E, 2000) |
"Body weight was also negatively correlated with dose." | 1.31 | Modulation of the inflammatory response in the rat TMJ with increasing doses of complete Freund's adjuvant. ( Bellinger, LL; Harper, RP; Kerins, CA; McIntosh, JE; Spears, R, 2001) |
"In these situations fever is often present." | 1.28 | The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat. ( Aarden, LA; Helle, M; van Gool, J; van Vugt, H, 1990) |
"Fever was continuously recorded and 24 h after induction acute phase reactant (APR) response was measured as indicated by the rise of alpha-macrofetoprotein (alpha M FP, alpha 2 macroglobulin of the rat)." | 1.27 | Fever and acute phase reactants in the rat. ( Deutz, NE; van Gool, J; van Vugt, H, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (12.12) | 18.7374 |
1990's | 13 (39.39) | 18.2507 |
2000's | 10 (30.30) | 29.6817 |
2010's | 6 (18.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Thomsen, KL | 2 |
Luna-Moreno, D | 1 |
Aguilar-Roblero, R | 1 |
Díaz-Muñoz, M | 1 |
Arambasić, J | 1 |
Poznanović, G | 2 |
Ivanović-Matić, S | 2 |
Bogojević, D | 1 |
Mihailović, M | 1 |
Uskoković, A | 1 |
Grigorov, I | 1 |
Martin, LB | 1 |
Alam, JL | 1 |
Imboma, T | 1 |
Liebl, AL | 1 |
Merchant, S | 1 |
Huang, N | 1 |
Korbelik, M | 1 |
Pacheco-López, G | 1 |
Giovanoli, S | 1 |
Langhans, W | 1 |
Meyer, U | 1 |
Jessen, N | 1 |
Møller, AB | 1 |
Aagaard, NK | 1 |
Grønbæk, H | 1 |
Holst, JJ | 1 |
Vilstrup, H | 1 |
Kelley, GL | 1 |
Allan, G | 1 |
Azhar, S | 1 |
Bernotiene, E | 1 |
Palmer, G | 1 |
Talabot-Ayer, D | 1 |
Szalay-Quinodoz, I | 1 |
Aubert, ML | 1 |
Gabay, C | 1 |
Stuyt, RJ | 1 |
Netea, MG | 1 |
Verschueren, I | 1 |
Dinarello, CA | 2 |
Kullberg, BJ | 1 |
van der Meer, JW | 1 |
Owen-Ashley, NT | 1 |
Turner, M | 1 |
Hahn, TP | 1 |
Wingfield, JC | 1 |
Breuner, CW | 1 |
Lynn, SE | 1 |
Julian, GE | 1 |
Cornelius, JM | 1 |
Heidinger, BJ | 1 |
Love, OP | 1 |
Sprague, RS | 1 |
Wada, H | 1 |
Whitman, BA | 1 |
Castrogiovanni, D | 1 |
Gaillard, RC | 2 |
Giovambattista, A | 2 |
Spinedi, E | 2 |
Conn, CA | 1 |
Kozak, WE | 1 |
Tooten, PC | 1 |
Niewold, TA | 1 |
Borer, KT | 1 |
Kluger, MJ | 1 |
Fattori, E | 1 |
Cappelletti, M | 2 |
Costa, P | 1 |
Sellitto, C | 1 |
Cantoni, L | 1 |
Carelli, M | 1 |
Faggioni, R | 1 |
Fantuzzi, G | 2 |
Ghezzi, P | 2 |
Poli, V | 2 |
Turnbull, AV | 1 |
Dow, RC | 1 |
Hopkins, SJ | 1 |
White, A | 1 |
Fink, G | 1 |
Rothwell, NJ | 1 |
Exton, MS | 1 |
Bull, DF | 1 |
King, MG | 1 |
Husband, AJ | 1 |
Benigni, F | 1 |
Sacco, S | 1 |
Sironi, M | 1 |
Pozzi, P | 1 |
Sipe, JD | 2 |
Paonessa, G | 1 |
Pennica, D | 1 |
Panayotatos, N | 1 |
Lee, S | 1 |
Rivier, C | 1 |
Eastman, HB | 1 |
Fawcett, TW | 1 |
Udelsman, R | 1 |
Holbrook, NJ | 1 |
Chisari, AN | 1 |
Corró, L | 1 |
Kumon, Y | 1 |
Suehiro, T | 1 |
Hashimoto, K | 1 |
Harper, RP | 1 |
Kerins, CA | 1 |
McIntosh, JE | 1 |
Spears, R | 1 |
Bellinger, LL | 1 |
Elenkov, IJ | 1 |
Kovács, K | 1 |
Kiss, J | 1 |
Bertók, L | 1 |
Vizi, ES | 1 |
Soudan, B | 1 |
Tetaert, D | 1 |
Racadot, A | 1 |
Degand, P | 1 |
Boersma, A | 1 |
van Gool, J | 2 |
van Vugt, H | 2 |
Helle, M | 1 |
Aarden, LA | 1 |
Lobo, RA | 1 |
Limãos, EA | 1 |
McIntyre, KW | 1 |
Stepan, GJ | 1 |
Kolinsky, KD | 1 |
Benjamin, WR | 1 |
Plocinski, JM | 1 |
Kaffka, KL | 1 |
Campen, CA | 1 |
Chizzonite, RA | 1 |
Kilian, PL | 1 |
Deutz, NE | 1 |
Okamoto, H | 1 |
Hanaoka, M | 1 |
Yayama, K | 1 |
Ohtani, R | 1 |
Itoh, N | 1 |
Martin, LW | 1 |
Deeter, LB | 1 |
Lipton, JM | 1 |
Amrani, DL | 1 |
Mauzy-Melitz, D | 1 |
Mosesson, MW | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Double-Blind, Randomized, Placebo-Controlled, First-in-Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Orally Administered DF-003 Following Single (Part 1) and Multiple (Part 2) Ascending Doses in Healthy Subjects[NCT05997641] | Phase 1 | 96 participants (Anticipated) | Interventional | 2023-09-15 | Recruiting | ||
Beta-Blockers and Inflammatory Responses to Acute Psychosocial Stress[NCT02972554] | Phase 4 | 92 participants (Actual) | Interventional | 2016-01-26 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Measured in blood plasma using enzyme-linked immunosorbent assay. Log-transformed prior to analysis to correct for skew in data. Four different change scores were calculated: first, change at post-drug from pre-drug baseline; second, the change at 30-min post-stressor from post-drug baseline; third, change at 60-min post-stressor from post-drug baseline; and fourth, change at 90-min post-stressor from post-drug baseline. (NCT02972554)
Timeframe: Pre-drug baseline; 60-min post-drug administration baseline before stressor; 30-min post-stressor; 60-min post-stressor; 90-min post-stressor
Intervention | log(picograms/mL) (Mean) | |||
---|---|---|---|---|
Post-drug from pre-drug baseline | 30-min post-stress from post-drug baseline | 60-min post-stress from post-drug baseline | 90-min post-stress from post-drug baseline | |
Placebo | .16 | .24 | .19 | .46 |
Propanolol Hydrochloride | .05 | .31 | .32 | .48 |
"Self-report measure of affect (emotion) state using the Positive & Negative Affect Schedule Negative Affect (PANAS). Answered on a Likert scale from 0 (not at all) - 6 (very much). Mean score range is from 0-6. Higher numbers indicate more negative, high arousal emotions; low numbers indicate less negative, high arousal emotions. Three change scores were calculated from the four different rating measurement time points: a change in negative, high arousal emotions at the post-drug baseline from the pre-drug baseline; a change in emotions right before the Trier Social Stress Task (TSST) from the post-drug baseline; and a change in emotions during the TSST from the post-drug baseline." (NCT02972554)
Timeframe: Pre-drug baseline; 60-min post-drug administration baseline before stressor; 2-min before the stressor; 1-min post-stressor
Intervention | score on a scale (Mean) | ||
---|---|---|---|
Post-drug from pre-drug baseline | TSST-prep from post-drug baseline | TSST stressor from post-drug baseline | |
Placebo | -.13 | .37 | .76 |
Propanolol Hydrochloride | -.10 | .18 | .61 |
Mean level pre-ejection period (PEP; centered at zero) derived from impedance cardiography and electrocardiogram. Four different change scores were calculated: first, the change in average PEP from the 5-min pre-drug baseline to the 5-min post-drug baselines; second, the change in average PEP that occurred during the 2-min anticipatory stress speech preparation phase of the Trier Social Stress Test (TSST) from the post-drug baseline; third, the change in average PEP that occurred across the 15-min of the TSST (speech + math tasks) from the post-drug baseline; fourth and finally, the change in average PEP that occurred across 7-min in a post-stressor recovery period as compared to the post-drug baseline. (NCT02972554)
Timeframe: Pre-drug baseline; 60-min post-drug administration baseline before stressor; 2-min before the stressor; 15-min during stressor, 7-min recovery post-stressor
Intervention | milliseconds (Mean) | |||
---|---|---|---|---|
Post-drug from pre-drug baseline | TSST-prep from post-drug baseline | TSST from post-drug baseline | Post-stress recovery from post-drug baseline | |
Placebo | .86 | -10.92 | -10.69 | -1.19 |
Propanolol Hydrochloride | 7.14 | -5.33 | -.80 | .21 |
Mean level respiratory sinus arrhythmia (RSA) derived from electrocardiogram; measure of heart rate variability assessed as the ratio of low-to-high frequencies in the respiratory-cardiac power spectrum. Four different change scores were calculated: first, the change in average RSA from the 5-min pre-drug baseline to the 5-min post-drug baselines; second, the change in average RSA that occurred during the 2-min anticipatory stress speech preparation phase of the Trier Social Stress Test (TSST) from the post-drug baseline; third, the change in average RSA that occurred across the 15-min of the TSST (speech + math tasks) from the post-drug baseline; fourth and finally, the change in average RSA that occurred across 7-min in a post-stressor recovery period as compared to the post-drug baseline. (NCT02972554)
Timeframe: Pre-drug baseline; 60-min post-drug administration baseline before stressor; 2-min before the stressor; 15-min during stressor, 7-min recovery post-stressor
Intervention | Ratio (Mean) | |||
---|---|---|---|---|
Post-drug from pre-drug baseline | TSST-prep from post-drug baseline | TSST from post-drug baseline | Post-stress recovery from post-drug baseline | |
Placebo | .27 | -.43 | -.87 | -.26 |
Propanolol Hydrochloride | .11 | .36 | -.06 | .36 |
Concentration of alpha amylase in saliva quantified quantified by enzyme kinetic method. Two different change scores were calculated: first, the pre-drug to post-drug baseline change and, second, the 15-min post-stressor change from post-drug baseline. (NCT02972554)
Timeframe: Pre-drug baseline; 60-min post-drug administration baseline before stressor; 15-min post-stressor
Intervention | picograms / mL (Mean) | |
---|---|---|
Post-drug from pre-drug baseline | 15-min post-stress from post-drug baseline | |
Placebo | -6.36 | 6.73 |
Propanolol Hydrochloride | -7.50 | -15.68 |
Concentration of cortisol in saliva quantified quantified by chemiluminescence immunoassay with high sensitivity. Three different change scores were calculated from pre-drug to post-drug baselines, 15-min post-stressor from post-drug baseline, and 30-min post-stressor from post-drug baseline. (NCT02972554)
Timeframe: Pre-drug baseline; 60-min post-drug administration baseline before stressor; 15-min post-stressor; 30-min post-stressor
Intervention | nanomole/L (Mean) | ||
---|---|---|---|
Post-drug from pre-drug baseline | 15-min post-stress from post-drug baseline | 30-min post-stress from post-drug baseline | |
Placebo | -3.76 | 4.02 | 1.86 |
Propanolol Hydrochloride | -6.42 | 5.61 | 2.1 |
1 review available for corticosterone and Acute-Phase Reaction
Article | Year |
---|---|
Regulation of urea synthesis during the acute phase response in rats.
Topics: Acute-Phase Proteins; Acute-Phase Reaction; Animals; Blood Glucose; Corticosterone; Gene Expression; | 2013 |
32 other studies available for corticosterone and Acute-Phase Reaction
Article | Year |
---|---|
Restricted feeding entrains rhythms of inflammation-related factors without promoting an acute-phase response.
Topics: Acute-Phase Reaction; Animals; C-Reactive Protein; Circadian Rhythm; Corticosterone; Fasting; Feedin | 2009 |
Association of the glucocorticoid receptor with STAT3, C/EBPbeta, and the hormone-responsive element within the rat haptoglobin gene promoter during the acute phase response.
Topics: Acute-Phase Reaction; Animals; Base Sequence; CCAAT-Enhancer-Binding Protein-beta; Corticosterone; G | 2010 |
Variation in inflammation as a correlate of range expansion in Kenyan house sparrows.
Topics: Acute-Phase Reaction; Animals; Body Size; Corticosterone; Female; Freund's Adjuvant; Haptoglobins; I | 2010 |
Expression of complement and pentraxin proteins in acute phase response elicited by tumor photodynamic therapy: the engagement of adrenal hormones.
Topics: Acute-Phase Reaction; Animals; C-Reactive Protein; Carcinoma, Lewis Lung; Complement System Proteins | 2010 |
Priming of metabolic dysfunctions by prenatal immune activation in mice: relevance to schizophrenia.
Topics: Acute-Phase Reaction; Animals; Body Composition; Corticosterone; Cytokines; Disease Models, Animal; | 2013 |
Regulation of urea synthesis during the acute-phase response in rats.
Topics: Acute-Phase Reaction; Animals; Blood Glucose; Corticosterone; Female; Glucagon; I-kappa B Proteins; | 2013 |
High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation.
Topics: Acute-Phase Reaction; Animals; Corticosterone; Dietary Carbohydrates; Fructose; Hypercholesterolemia | 2004 |
Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice.
Topics: Acute Disease; Acute-Phase Reaction; Animals; Arthritis, Experimental; Corticosterone; Cytokines; Ed | 2004 |
Interleukin-18 does not modulate the acute-phase response.
Topics: Acute-Phase Reaction; Animals; Body Temperature; Cholesterol; Corticosterone; Fever; Glucocorticoids | 2005 |
Hormonal, behavioral, and thermoregulatory responses to bacterial lipopolysaccharide in captive and free-living white-crowned sparrows (Zonotrichia leucophrys gambelii).
Topics: Acute-Phase Reaction; Aggression; Animals; Behavior, Animal; Body Temperature Regulation; Body Weigh | 2006 |
Plasma-binding globulins and acute stress response.
Topics: Acute-Phase Reaction; Animals; Birds; Body Constitution; Charadriiformes; Corticosterone; Falconifor | 2006 |
Neuroendocrine, metabolic, and immune functions during the acute phase response of inflammatory stress in monosodium L-glutamate-damaged, hyperadipose male rat.
Topics: Acute-Phase Reaction; Adiposity; Adrenocorticotropic Hormone; Animals; Carbohydrates; Corticosterone | 2008 |
Effect of exercise and food restriction on selected markers of the acute phase response in hamsters.
Topics: Acute-Phase Reaction; Amyloid; Animals; Body Temperature; Body Weight; Corticosterone; Cricetinae; E | 1995 |
Defective inflammatory response in interleukin 6-deficient mice.
Topics: Acute-Phase Reaction; Animals; Anorexia; Corticosterone; Hypoglycemia; Inflammation; Interleukin-1; | 1994 |
Mechanisms of activation of the pituitary-adrenal axis by tissue injury in the rat.
Topics: Acute-Phase Reaction; Adrenocorticotropic Hormone; Afferent Pathways; Animals; Animals, Newborn; Aro | 1994 |
HI-6 therapy and the acute phase response in the rat.
Topics: Acute-Phase Proteins; Acute-Phase Reaction; Animals; Antidotes; Atropine; Blood Proteins; Blotting, | 1996 |
Paradoxical conditioning of the plasma copper and corticosterone responses to bacterial endotoxin.
Topics: Acute-Phase Reaction; Animals; Conditioning, Classical; Copper; Corticosterone; Endotoxins; Feeding | 1995 |
Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1.
Topics: Acute-Phase Reaction; Animals; Antigens, CD; Ciliary Neurotrophic Factor; Corticosterone; Cytokine R | 1996 |
Gender differences in the effect of prenatal alcohol exposure on the hypothalamic-pituitary-adrenal axis response to immune signals.
Topics: Acute-Phase Reaction; Adrenocorticotropic Hormone; Animals; Arousal; Corticosterone; Corticotropin-R | 1996 |
Effects of perturbations of the hypothalamic-pituitary-adrenal axis on the acute phase response: altered C/EBP and acute phase response gene expression in lipopolysaccharide-treated rats.
Topics: Acute-Phase Proteins; Acute-Phase Reaction; Adrenalectomy; Animals; CCAAT-Enhancer-Binding Proteins; | 1996 |
Metabolic, neuroendocrine and immune functions in basal conditions and during the acute-phase response to endotoxic shock in undernourished rats.
Topics: Acute-Phase Reaction; Adipocytes; Adrenocorticotropic Hormone; Aging; Animals; Blood Glucose; Cortic | 2000 |
Dexamethasone, but not IL-1 alone, upregulates acute-phase serum amyloid A gene expression and production by cultured human aortic smooth muscle cells.
Topics: Acute-Phase Reaction; Adult; Aldosterone; Aorta; Arteriosclerosis; Cells, Cultured; Corticosterone; | 2001 |
Modulation of the inflammatory response in the rat TMJ with increasing doses of complete Freund's adjuvant.
Topics: Acute-Phase Reaction; Analysis of Variance; Animals; Biomarkers; Body Weight; Corticosterone; Dose-R | 2001 |
Lipopolysaccharide is able to bypass corticotrophin-releasing factor in affecting plasma ACTH and corticosterone levels: evidence from rats with lesions of the paraventricular nucleus.
Topics: Acute-Phase Reaction; Adrenocorticotropic Hormone; Animals; Corticosterone; Corticotropin-Releasing | 1992 |
Decrease of testosterone level during an experimental African trypanosomiasis: involvement of a testicular LH receptor desensitization.
Topics: Acute-Phase Reaction; Animals; Blood Glucose; Chorionic Gonadotropin; Corticosterone; Disease Models | 1992 |
The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat.
Topics: Acute-Phase Proteins; Acute-Phase Reaction; Adrenergic beta-Antagonists; Animals; Corticosterone; Di | 1990 |
Inflammatory response modulated by pinealectomy: effect of light.
Topics: Acute-Phase Reaction; Adrenalectomy; Animals; Carrageenan; Corticosterone; Female; Light; Melatonin; | 1991 |
Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.
Topics: Acute-Phase Reaction; Animals; Antibodies, Monoclonal; Binding, Competitive; Bone Marrow Cells; Case | 1991 |
Fever and acute phase reactants in the rat.
Topics: Acute-Phase Proteins; Acute-Phase Reaction; Adrenalectomy; Animals; Atenolol; Autonomic Nerve Block; | 1988 |
Acute-phase response of angiotensinogen in rat adjuvant arthritis.
Topics: Acute-Phase Reaction; alpha-Macroglobulins; Angiotensinogen; Animals; Arthritis; Arthritis, Experime | 1989 |
Acute-phase response to endogenous pyrogen in rabbit: effects of age and route of administration.
Topics: Acute-Phase Reaction; Age Factors; alpha-MSH; Animals; Corticosterone; Female; Inflammation; Injecti | 1989 |
Effect of hepatocyte-stimulating factor and glucocorticoids on plasma fibronectin levels.
Topics: Acute-Phase Reaction; Animals; Chickens; Chromatography, Gel; Corticosterone; Dexamethasone; Fibrino | 1986 |